Proliferative	0	13	O
diabetic	14	22	O
retinopathy	23	34	O
is	35	37	O
associated	38	48	O
with	49	53	O
a	54	55	O
low	56	59	O
level	60	65	O
of	66	68	O
the	69	72	O
natural	73	80	O
ocular	81	87	B-Organ
anti	88	92	O
-	92	93	O
angiogenic	93	103	O
agent	104	109	O
pigment	110	117	B-Gene_or_gene_product
epithelium	118	128	I-Gene_or_gene_product
-	128	129	I-Gene_or_gene_product
derived	129	136	I-Gene_or_gene_product
factor	137	143	I-Gene_or_gene_product
(	144	145	O
PEDF	145	149	B-Gene_or_gene_product
)	149	150	O
in	151	153	O
aqueous	154	161	B-Organism_substance
humor	162	167	I-Organism_substance
.	167	168	O

a	169	170	O
pilot	171	176	O
study	177	182	O
.	182	183	O

Retinopathy	185	196	O
is	197	199	O
the	200	203	O
most	204	208	O
common	209	215	O
microvascular	216	229	B-Tissue
diabetes	230	238	O
complication	239	251	O
and	252	255	O
represents	256	266	O
a	267	268	O
major	269	274	O
threat	275	281	O
to	282	284	O
the	285	288	O
eyesight	289	297	O
.	297	298	O

The	299	302	O
aim	303	306	O
of	307	309	O
this	310	314	O
study	315	320	O
was	321	324	O
to	325	327	O
address	328	335	O
the	336	339	O
role	340	344	O
of	345	347	O
pro	348	351	O
-	351	352	O
and	353	356	O
anti	357	361	O
-	361	362	O
angiogenic	362	372	O
molecules	373	382	O
in	383	385	O
diabetic	386	394	O
retinopathy	395	406	O
in	407	409	O
the	410	413	O
aqueous	414	421	B-Organism_substance
humor	422	427	I-Organism_substance
of	428	430	O
the	431	434	O
eye	435	438	B-Organ
.	438	439	O

Aqueous	440	447	B-Organism_substance
humor	448	453	I-Organism_substance
was	454	457	O
collected	458	467	O
at	468	470	O
cataract	471	479	O
surgery	480	487	O
from	488	492	O
19	493	495	O
diabetic	496	504	O
patients	505	513	B-Organism
and	514	517	O
from	518	522	O
13	523	525	O
age	526	529	O
-	529	530	O
and	531	534	O
sex	535	538	O
-	538	539	O
matched	539	546	O
normoglycemic	547	560	O
controls	561	569	B-Organism
.	569	570	O

Levels	571	577	O
of	578	580	O
pro	581	584	O
-	584	585	O
angiogenic	585	595	O
vascular	596	604	B-Gene_or_gene_product
endothelial	605	616	I-Gene_or_gene_product
growth	617	623	I-Gene_or_gene_product
factor	624	630	I-Gene_or_gene_product
(	631	632	O
VEGF	632	636	B-Gene_or_gene_product
)	636	637	O
and	638	641	O
angiogenic	642	652	O
inhibitor	653	662	O
pigment	663	670	B-Gene_or_gene_product
epithelium	671	681	I-Gene_or_gene_product
-	681	682	I-Gene_or_gene_product
derived	682	689	I-Gene_or_gene_product
factor	690	696	I-Gene_or_gene_product
(	697	698	O
PEDF	698	702	B-Gene_or_gene_product
)	702	703	O
were	704	708	O
determined	709	719	O
.	719	720	O

Angiogenic	721	731	O
activity	732	740	O
of	741	743	O
the	744	747	O
aqueous	748	755	B-Organism_substance
humor	756	761	I-Organism_substance
was	762	765	O
quantified	766	776	O
by	777	779	O
measuring	780	789	O
its	790	793	O
effect	794	800	O
on	801	803	O
the	804	807	O
migration	808	817	O
of	818	820	O
capillary	821	830	B-Cell
endothelial	831	842	I-Cell
cells	843	848	I-Cell
.	848	849	O

In	850	852	O
the	853	856	O
aqueous	857	864	B-Organism_substance
fluid	865	870	I-Organism_substance
,	870	871	O
VEGF	872	876	B-Gene_or_gene_product
levels	877	883	O
were	884	888	O
increased	889	898	O
in	899	901	O
diabetics	902	911	O
(	912	913	O
mean	913	917	O
values	918	924	O
:	924	925	O
501	926	929	O
vs	930	932	O
.	932	933	O
367	934	937	O
pg	938	940	O
/	940	941	O
ml	941	943	O
;	943	944	O
p	945	946	O
=	947	948	O
0	949	950	O
.	950	951	O
05	951	953	O
)	953	954	O
,	954	955	O
compared	956	964	O
to	965	967	O
controls	968	976	O
.	976	977	O

PEDF	978	982	B-Gene_or_gene_product
was	983	986	O
found	987	992	O
to	993	995	O
be	996	998	O
decreased	999	1008	O
in	1009	1011	O
diabetics	1012	1021	O
(	1022	1023	O
mean	1023	1027	O
values	1028	1034	O
:	1034	1035	O
2080	1036	1040	O
vs	1041	1043	O
.	1043	1044	O
5780	1045	1049	O
ng	1050	1052	O
/	1052	1053	O
ml	1053	1055	O
;	1055	1056	O
p	1057	1058	O
=	1059	1060	O
0	1061	1062	O
.	1062	1063	O
04	1063	1065	O
)	1065	1066	O
compared	1067	1075	O
to	1076	1078	O
controls	1079	1087	O
.	1087	1088	O

In	1089	1091	O
seven	1092	1097	O
diabetic	1098	1106	O
patients	1107	1115	B-Organism
with	1116	1120	O
proliferative	1121	1134	O
retinopathy	1135	1146	O
,	1146	1147	O
the	1148	1151	O
most	1152	1156	O
profound	1157	1165	O
finding	1166	1173	O
was	1174	1177	O
a	1178	1179	O
significant	1180	1191	O
decrease	1192	1200	O
of	1201	1203	O
the	1204	1207	O
PEDF	1208	1212	B-Gene_or_gene_product
level	1213	1218	O
(	1219	1220	O
mean	1220	1224	O
value	1225	1230	O
:	1230	1231	O
237	1232	1235	O
ng	1236	1238	O
/	1238	1239	O
ml	1239	1241	O
)	1241	1242	O
,	1242	1243	O
whereas	1244	1251	O
VEGF	1252	1256	B-Gene_or_gene_product
levels	1257	1263	O
were	1264	1268	O
comparable	1269	1279	O
to	1280	1282	O
diabetic	1283	1291	O
patients	1292	1300	B-Organism
without	1301	1308	O
proliferation	1309	1322	O
(	1323	1324	O
mean	1324	1328	O
value	1329	1334	O
:	1334	1335	O
3153	1336	1340	O
;	1340	1341	O
p	1342	1343	O
=	1344	1345	O
0	1346	1347	O
.	1347	1348	O
003	1348	1351	O
)	1351	1352	O
.	1352	1353	O

Angiogenic	1354	1364	O
activity	1365	1373	O
in	1374	1376	O
samples	1377	1384	O
of	1385	1387	O
patients	1388	1396	B-Organism
from	1397	1401	O
the	1402	1405	O
control	1406	1413	O
group	1414	1419	O
was	1420	1423	O
generally	1424	1433	O
inhibitory	1434	1444	O
due	1445	1448	O
to	1449	1451	O
PEDF	1452	1456	B-Gene_or_gene_product
,	1456	1457	O
and	1458	1461	O
inhibition	1462	1472	O
was	1473	1476	O
blocked	1477	1484	O
by	1485	1487	O
neutralizing	1488	1500	O
antibodies	1501	1511	O
to	1512	1514	O
PEDF	1515	1519	B-Gene_or_gene_product
.	1519	1520	O

Likewise	1521	1529	O
,	1529	1530	O
in	1531	1533	O
diabetics	1534	1543	O
without	1544	1551	O
proliferation	1552	1565	O
,	1565	1566	O
angiogenic	1567	1577	O
activity	1578	1586	O
was	1587	1590	O
also	1591	1595	O
blocked	1596	1603	O
by	1604	1606	O
antibodies	1607	1617	O
to	1618	1620	O
PEDF	1621	1625	B-Gene_or_gene_product
.	1625	1626	O

We	1627	1629	O
will	1630	1634	O
demonstrate	1635	1646	O
here	1647	1651	O
that	1652	1656	O
the	1657	1660	O
level	1661	1666	O
of	1667	1669	O
the	1670	1673	O
natural	1674	1681	O
ocular	1682	1688	O
anti	1689	1693	O
-	1693	1694	O
angiogenic	1694	1704	O
agent	1705	1710	O
PEDF	1711	1715	B-Gene_or_gene_product
is	1716	1718	O
inversely	1719	1728	O
associated	1729	1739	O
with	1740	1744	O
proliferative	1745	1758	O
retinopathy	1759	1770	O
.	1770	1771	O

PEDF	1772	1776	B-Gene_or_gene_product
is	1777	1779	O
an	1780	1782	O
important	1783	1792	O
negative	1793	1801	O
regulator	1802	1811	O
of	1812	1814	O
angiogenic	1815	1825	O
activity	1826	1834	O
of	1835	1837	O
aqueous	1838	1845	B-Organism_substance
humor	1846	1851	I-Organism_substance
.	1851	1852	O

Our	1853	1856	O
data	1857	1861	O
may	1862	1865	O
have	1866	1870	O
implications	1871	1883	O
for	1884	1887	O
the	1888	1891	O
development	1892	1903	O
of	1904	1906	O
novel	1907	1912	O
regimens	1913	1921	O
for	1922	1925	O
diabetic	1926	1934	O
retinopathy	1935	1946	O
.	1946	1947	O

